Literature DB >> 9013723

Protein phosphatases control MAP kinase activation and microtubule organization during rat oocyte maturation.

M Zernicka-Goetz1, M H Verlhac, G Géraud, J Z Kubiak.   

Abstract

Mitogen-activated protein kinase (MAP) is involved in many signal transduction pathways and is activated during meiotic maturation in various species. In this study, we used the rat oocyte to identify some of the control mechanisms involved in MAP kinase activation which is triggered at resumption of meiosis. We examined the respective contribution of this kinase and maturation promoting factor (MPF), or cdc2 kinase, in the regulation of microtubule behavior and in the reorganization of chromatin during meiotic maturation. We found that the resumption of meiotic division in rat oocytes coincided with the activation of MPF and was followed 3 h later by the activation of MAP kinase. The activation of the two kinases also occurred in oocytes undergoing maturation in the presence of the protein phosphatase inhibitor okadaic acid (OA). However, the activation of cdc2 kinase was only partial, whereas activation of MAP kinase was accelerated and began 1 h after the resumption of meiosis, i.e. 2 h earlier than in control oocytes. We also showed that protein synthesis was required to activate MAP kinase, but not cdc2 kinase. However, once MAP kinase was activated, ongoing protein synthesis was not necessary to maintain its activity. These results suggest that a negative regulation of MAP kinase slows down its activation at the resumption of meiosis, mediated through the level of phosphatase activity. Moreover, MAP kinase activation requires protein synthesis, even upon phosphatase inactivation by OA, suggesting also the existence of a positive control pathway. We observed that during the first meiotic M-phase, the spindle did not form immediately after cdc2 kinase activation, but that its formation coincided with the appearance of MAP kinase activity. However, earlier activation of MAP kinase by treatment with OA did not lead to premature spindle formation, but instead a large aster formed consisting of long microtubules radiating from the condensed chromatin. In OA-treated oocytes, spindles did not form and an interphase network of microtubule developed with time. Thus, MAP kinase is unable to substitute for MPF under these conditions, its activity alone being insufficient to maintain the progression through meiotic maturation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013723

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  5 in total

1.  The intracellular pH-regulatory HCO3-/Cl- exchanger in the mouse oocyte is inactivated during first meiotic metaphase and reactivated after egg activation via the MAP kinase pathway.

Authors:  Karen P Phillips; Mary Ann F Petrunewich; Jennifer L Collins; Jay M Baltz
Journal:  Mol Biol Cell       Date:  2002-11       Impact factor: 4.138

2.  A comparative genome analysis of gene expression reveals different regulatory mechanisms between mouse and human embryo pre-implantation development.

Authors:  Kan He; Hongbo Zhao; Qishan Wang; Yuchun Pan
Journal:  Reprod Biol Endocrinol       Date:  2010-05-11       Impact factor: 5.211

Review 3.  G2/M transition of pig oocytes: How do oocytes initiate maturation?

Authors:  Takashi Miyano; Jibak Lee; Josef Fulka
Journal:  Reprod Med Biol       Date:  2003-09-26

4.  MPF governs the assembly and contraction of actomyosin rings by activating RhoA and MAPK during chemical-induced cytokinesis of goat oocytes.

Authors:  Yan-Guang Wu; Ping Zhou; Guo-Cheng Lan; Da Gao; Qing Li; De-Li Wei; Hui-Li Wang; Jing-He Tan
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

5.  Okadaic acid, an inhibitor of protein phosphatase 1 and 2A, induces premature separation of sister chromatids during meiosis I and aneuploidy in mouse oocytes in vitro.

Authors:  John B Mailhes; Colette Hilliard; John W Fuseler; Steve N London
Journal:  Chromosome Res       Date:  2003       Impact factor: 4.620

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.